DNA topoisomerase I--targeting drugs
Arakawa, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 2): 174-177
2015
ISSN/ISBN: 0047-1852 PMID: 25831746 Document Number: 680242
Document emailed within 1 workday
Related Documents
Gutzler, F. 1996: New drugs. Topoisomerase inhibitors Zentralblatt für Gynakologie 118(10): 579Szmigiero, L. 1988: Topoisomerase Ii as a cellular receptor of various antineoplastic drugs Postepy Biochemii 34(3): 147-152
Coleman, L.W.; Bronstein, I.B.; Holden, J.A. 2001: Immunohistochemical staining for DNA topoisomerase I, DNA topoisomerase II-alpha and p53 in gastric carcinomas Anticancer Research 21(2a): 1167-1172
Herzog, C.E.; Holmes, K.A.; Tuschong, L.M.; Ganapathi, R.; Zwelling, L.A. 1998: Absence of topoisomerase IIbeta in an amsacrine-resistant human leukemia cell line with mutant topoisomerase IIalpha Cancer Research 58(23): 5298-5300
Meikle, I.; Cummings, J.; Macpherson, J.S.; Smyth, J.F. 1995: Identification of anthracenyl-dipeptide conjugates as novel topoisomerase i and Ii inhibitors and their evaluation as potential anticancer drugs Anti-Cancer Drug Design 10(7): 515-527
de Tinguy-Moreaud, E.; Pourquier, P.; Montaudon, D.; Robert, J. 1994: Relationships between DNA damage and growth inhibition induced by topoisomerase II-interfering drugs in doxorubicin-sensitive and -resistant rat glioblastoma cells Anticancer Research 14(1a): 99-103
Harker, W.G.; Slade, D.L.; Parr, R.L.; Feldhoff, P.W.; Sullivan, D.M.; Holguin, M.H. 1995: Alterations in the topoisomerase Ii alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase Ii beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line Cancer Research 55(8): 1707-1716
Wu, G.-f. 2005: New techniques for screening drugs targeting at RNAs Yao Xue Xue Bao 40(12): 1064-1068
Zhang, Y.-H.; Tian, J.-D.; Peng, S.-X. 2006: Targeting of nitric oxide-donor and related drugs Yao Xue Xue Bao 41(6): 481-486
Takashima, A.; Fukuda, H.; Shibata, T. 2010: Development for and clinical trials of molecular targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 822-827
Tang, Q.; Ding, Q.; Lin, L.; Zhang, Z.-z.; Dai, Z.; Zhan, J.-b. 2012: Development of antibody drugs targeting against HER2 for cancer therapy Yao Xue Xue Bao 47(10): 1297-1305
Ho, Y.H.; Evans, D.F.; Hardcastle, J.D. 1999: Direct mucosal targeting of colonic receptors by prokinetic drugs in an experimental model Annals of the Academy of Medicine Singapore 28(1): 31-36
Aimono, Y.; Nemoto, M.; Sato, W.; Saito, Y.; Aoyama, Y.; Joko, F.; Maruyama, T.; Kamoshida, T. 2013: Examination of the usefulness of the pharmacists' outpatient clinic for treatment with oral molecule-targeting drugs Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(7): 901-905
Boltaev, A.A.; El-Bassel, N.; Deryabina, A.P.; Terlikbaeva, A.; Gilbert, L.; Hunt, T.; Primbetova, S.; Strathdee, S.A. 2013: Scaling up HIV prevention efforts targeting people who inject drugs in Central Asia: a review of key challenges and ways forward Drug and Alcohol Dependence 132 Suppl. 1: S41-S47
Fan, J.Z.; Li, T.L.; Pang, Q.J.; Guan, C.T.; He, Y.; Su, K.Y. 1996: Preparation of hepatic targeting antivirus agent NGA-ACV and its targeting property Yao Xue Xue Bao 31(8): 585-590
Berger, G.; Reszka, R.; Pohlen, U.; Jung, M.; Lucas, S.; Buhr, H.J. 1998: Liposome encapsulation of cystostatic drugs and starch microspheres improve tumor targeting in locoregional therapy. An animal experiment study of CC 531 liver tumor Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 693-697
Sugiura, T.; Ariyoshi, Y. 1992: DNA topoisomerase inhibitor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(13): 2140-2145
Hino, M.; Niitani, H. 1993: DNA topoisomerase inhibitor Nihon Rinsho. Japanese Journal of Clinical Medicine 51(12): 3291-3300
Wrześniok, D.; Buszman, E.; Matusiński, B. 2003: Drugs ototoxicity. Part II. Loop diuretics, nonsteroidal anti-inflammatory drugs, antineoplastic and antimalarial drugs Wiadomosci Lekarskie 56(7-8): 369-374
Giaccone, G. 1994: DNA topoisomerases and topoisomerase inhibitors Pathologie-Biologie 42(4): 346-352